» Articles » PMID: 492326

Suppression of the Nonsense Mutation in Homozygous Beta 0 Thalassaemia

Overview
Journal Nature
Specialty Science
Date 1979 Oct 18
PMID 492326
Citations 25
Authors
Affiliations
Soon will be listed here.
Abstract

The common form of beta thalassaemia associated with elevated haemoglobin A2 levels can be broadly classified as beta + or beta 0 type according to the presence or absence of beta-globin chain synthesis in the homozygous state. The molecular pathology of each type is heterogeneous. Apart from a subgroup of Indo-Pakistani patients, the beta-globin structural gene is intact in the majority of patients with beta 0 thalassaemia. The amount of beta-globin mRNA present in the reticulocytes of these patients varies: in some it is absent or barely detectable; in others, a substantial amount is present, but it is nonfunctional. We recently demonstrated that the molecular lesion in a Chinese patient with nonfunctional beta-globin mRNA was due to the mutation of the normal lysine codon AAG at amino acid 17 to the amber terminator codon UAG, which prematurely terminates the beta-globin chain. In the present study we demonstrate the first example of a nonsense mutation in humans which can be suppressed in vitro by the suppressor tRNA, as has been found in other eukaryotic cells and viruses.

Citing Articles

The SARS-CoV-2 nucleocapsid protein interferes with the full enzymatic activation of UPF1 and its interaction with UPF2.

Nuccetelli V, Mghezzi-Habellah M, Deymier S, Roisin A, Gerard-Baraggia F, Rocchi C Nucleic Acids Res. 2025; 53(2).

PMID: 39831305 PMC: 11744187. DOI: 10.1093/nar/gkaf010.


TDP1 splice-site mutation causes HAP1 cell hypersensitivity to topoisomerase I inhibition.

Goh C, Bader A, Tran T, Belotserkovskaya R, DAlessandro G, Jackson S Nucleic Acids Res. 2024; 53(2.

PMID: 39660638 PMC: 11754736. DOI: 10.1093/nar/gkae1163.


Efficient suppression of premature termination codons with alanine by engineered chimeric pyrrolysine tRNAs.

Awawdeh A, Tapia A, Alshawi S, Dawodu O, Gaier S, Specht C Nucleic Acids Res. 2024; 52(22):14244-14259.

PMID: 39558163 PMC: 11662663. DOI: 10.1093/nar/gkae1048.


Splicing the Difference: Harnessing the Complexity of the Transcriptome in Hematopoiesis.

Maul-Newby H, Halene S Exp Hematol. 2024; 140():104655.

PMID: 39393608 PMC: 11732257. DOI: 10.1016/j.exphem.2024.104655.


Therapeutic Nonsense Suppression Modalities: From Small Molecules to Nucleic Acid-Based Approaches.

Morais P, Zhang R, Yu Y Biomedicines. 2024; 12(6).

PMID: 38927491 PMC: 11201248. DOI: 10.3390/biomedicines12061284.